Vera Therapeutics, Inc. (VERA)
NASDAQ: VERA · Real-Time Price · USD
42.60
+0.55 (1.31%)
Dec 20, 2024, 4:00 PM EST - Market closed
Vera Therapeutics Analyst Ratings
Total Analysts
9
Consensus Rating
Strong Buy
Price Target
$59.22
Upside
+39.01%
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Wells Fargo | Wells Fargo | Buy Initiates $70 | Buy | Initiates | $70 | +64.32% | Nov 21, 2024 |
| Wedbush | Wedbush | Hold Maintains $30 → $38 | Hold | Maintains | $30 → $38 | -10.80% | Nov 8, 2024 |
| JP Morgan | JP Morgan | Buy Maintains $72 → $75 | Buy | Maintains | $72 → $75 | +76.06% | Nov 5, 2024 |
| Guggenheim | Guggenheim | Strong Buy Maintains $56 → $64 | Strong Buy | Maintains | $56 → $64 | +50.23% | Oct 28, 2024 |
| Scotiabank | Scotiabank | Buy Initiates $60 | Buy | Initiates | $60 | +40.85% | Oct 16, 2024 |
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Reiterates $107 | Buy | Reiterates | $107 | +151.17% | Oct 3, 2024 |
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Reiterates $107 | Buy | Reiterates | $107 | +151.17% | Oct 1, 2024 |
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Reiterates $107 | Buy | Reiterates | $107 | +151.17% | Sep 23, 2024 |
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Reiterates $107 | Buy | Reiterates | $107 | +151.17% | Sep 16, 2024 |
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Reiterates $107 | Buy | Reiterates | $107 | +151.17% | Sep 9, 2024 |
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Reiterates $107 | Buy | Reiterates | $107 | +151.17% | Sep 6, 2024 |
| JP Morgan | JP Morgan | Buy Maintains $62 → $72 | Buy | Maintains | $62 → $72 | +69.01% | Sep 3, 2024 |
| JP Morgan | JP Morgan | Buy Maintains $65 → $62 | Buy | Maintains | $65 → $62 | +45.54% | Aug 13, 2024 |
| JP Morgan | JP Morgan | Buy Maintains $60 → $65 | Buy | Maintains | $60 → $65 | +52.58% | May 31, 2024 |
| Raymond James | Raymond James | Strong Buy Maintains $57 → $68 | Strong Buy | Maintains | $57 → $68 | +59.62% | May 10, 2024 |
| Guggenheim | Guggenheim | Strong Buy Reiterates $56 | Strong Buy | Reiterates | $56 | +31.46% | Apr 5, 2024 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 10 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.